These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 12527916

  • 1. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients.
    Honorio S, Agathanggelou A, Schuermann M, Pankow W, Viacava P, Maher ER, Latif F.
    Oncogene; 2003 Jan 09; 22(1):147-50. PubMed ID: 12527916
    [Abstract] [Full Text] [Related]

  • 2. Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer.
    Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han J, Park J.
    Cancer Res; 2003 Jul 01; 63(13):3743-6. PubMed ID: 12839968
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers.
    Agathanggelou A, Dallol A, Zöchbauer-Müller S, Morrissey C, Honorio S, Hesson L, Martinsson T, Fong KM, Kuo MJ, Yuen PW, Maher ER, Minna JD, Latif F.
    Oncogene; 2003 Mar 13; 22(10):1580-8. PubMed ID: 12629521
    [Abstract] [Full Text] [Related]

  • 4. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA, Crowell RE.
    Cancer Res; 2002 Apr 15; 62(8):2370-7. PubMed ID: 11956099
    [Abstract] [Full Text] [Related]

  • 5. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [Abstract] [Full Text] [Related]

  • 6. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER, Latif F.
    Oncogene; 2001 Nov 08; 20(51):7573-7. PubMed ID: 11709729
    [Abstract] [Full Text] [Related]

  • 7. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas.
    Dammann R, Takahashi T, Pfeifer GP.
    Oncogene; 2001 Jun 14; 20(27):3563-7. PubMed ID: 11429703
    [Abstract] [Full Text] [Related]

  • 8. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML, Tao Q, Fu L, Wong KY, Qiu GH, Law FB, Tin PC, Cheung WL, Lee PY, Tang JC, Tsao GS, Lam KY, Law S, Wong J, Srivastava G.
    Int J Oncol; 2006 Mar 14; 28(3):767-73. PubMed ID: 16465383
    [Abstract] [Full Text] [Related]

  • 9. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M, Ito G, Kondo M, Uchiyama M, Fukui T, Mori S, Yoshioka H, Ueda Y, Shimokata K, Sekido Y.
    Cancer Lett; 2005 Jul 08; 225(1):131-9. PubMed ID: 15922865
    [Abstract] [Full Text] [Related]

  • 10. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.
    Lung Cancer; 2007 Oct 08; 58(1):131-8. PubMed ID: 17606310
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
    Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP.
    Nat Genet; 2000 Jul 08; 25(3):315-9. PubMed ID: 10888881
    [Abstract] [Full Text] [Related]

  • 12. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
    Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, Maher ER, Latif F.
    Cancer Res; 2002 Oct 15; 62(20):5874-80. PubMed ID: 12384551
    [Abstract] [Full Text] [Related]

  • 13. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
    Honorio S, Agathanggelou A, Wernert N, Rothe M, Maher ER, Latif F.
    Oncogene; 2003 Jan 23; 22(3):461-6. PubMed ID: 12545168
    [Abstract] [Full Text] [Related]

  • 14. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
    Ahmed IA, Pusch CM, Hamed T, Rashad H, Idris A, El-Fadle AA, Blin N.
    Cancer Genet Cytogenet; 2010 Jun 23; 199(2):96-100. PubMed ID: 20471512
    [Abstract] [Full Text] [Related]

  • 15. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH.
    J Clin Oncol; 2004 Jun 15; 22(12):2363-70. PubMed ID: 15197197
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Frequent hypermethylation of the RASSF1A gene in prostate cancer.
    Liu L, Yoon JH, Dammann R, Pfeifer GP.
    Oncogene; 2002 Oct 03; 21(44):6835-40. PubMed ID: 12360410
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.